SE9600071D0 - New oral formulation of two active ingredients I - Google Patents

New oral formulation of two active ingredients I

Info

Publication number
SE9600071D0
SE9600071D0 SE9600071A SE9600071A SE9600071D0 SE 9600071 D0 SE9600071 D0 SE 9600071D0 SE 9600071 A SE9600071 A SE 9600071A SE 9600071 A SE9600071 A SE 9600071A SE 9600071 D0 SE9600071 D0 SE 9600071D0
Authority
SE
Sweden
Prior art keywords
proton pump
pump inhibitor
active ingredients
oral formulation
fixed formulation
Prior art date
Application number
SE9600071A
Other languages
English (en)
Inventor
Helene Depui
Agneta Hallgren
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20400969&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9600071(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9600071A priority Critical patent/SE9600071D0/sv
Publication of SE9600071D0 publication Critical patent/SE9600071D0/sv
Priority to US08/750,934 priority patent/US6183776B1/en
Priority to HU9904024A priority patent/HU229153B1/hu
Priority to DE69624907T priority patent/DE69624907T3/de
Priority to EE9700192A priority patent/EE04002B1/xx
Priority to TR97/00916T priority patent/TR199700916T1/xx
Priority to JP9525131A priority patent/JPH11501950A/ja
Priority to CN96193594A priority patent/CN1080125C/zh
Priority to KR1019970706236A priority patent/KR100490075B1/ko
Priority to CA002213996A priority patent/CA2213996C/en
Priority to NZ325977A priority patent/NZ325977A/xx
Priority to RU97116726/14A priority patent/RU2179453C2/ru
Priority to DK96944726T priority patent/DK0813424T4/da
Priority to AU13241/97A priority patent/AU712669B2/en
Priority to BRPI9607350-0A priority patent/BR9607350B1/pt
Priority to PT96944726T priority patent/PT813424E/pt
Priority to PL96322175A priority patent/PL187075B1/pl
Priority to MX9706785A priority patent/MX9706785A/es
Priority to PCT/SE1996/001737 priority patent/WO1997025066A1/en
Priority to ES96944726T priority patent/ES2185817T5/es
Priority to SK1169-97A priority patent/SK283695B6/sk
Priority to IL12165196A priority patent/IL121651A/xx
Priority to EP96944726A priority patent/EP0813424B2/en
Priority to AT96944726T priority patent/ATE228009T1/de
Priority to CZ19972747A priority patent/CZ293583B6/cs
Priority to UA97104949A priority patent/UA45392C2/uk
Priority to ARP960105899A priority patent/AR005281A1/es
Priority to TW085116139A priority patent/TW464514B/zh
Priority to ZA9610935A priority patent/ZA9610935B/xx
Priority to MYPI97000065A priority patent/MY116091A/en
Priority to EG1897A priority patent/EG23821A/xx
Priority to SA97170553A priority patent/SA97170553B1/ar
Priority to IS4548A priority patent/IS2716B/is
Priority to NO19974071A priority patent/NO326656B1/no
Priority to HK98100847A priority patent/HK1001763A1/xx
Priority to HK98111792A priority patent/HK1017992A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
SE9600071A 1996-01-08 1996-01-08 New oral formulation of two active ingredients I SE9600071D0 (sv)

Priority Applications (36)

Application Number Priority Date Filing Date Title
SE9600071A SE9600071D0 (sv) 1996-01-08 1996-01-08 New oral formulation of two active ingredients I
CZ19972747A CZ293583B6 (cs) 1996-01-08 1996-12-20 Vícesložková tabletová orální farmaceutická dávková forma, způsob její výroby a použití
UA97104949A UA45392C2 (uk) 1996-01-08 1996-12-20 Пероральна фармацевтична лікарська форма, що містить інгібітор протонного насоса і антацидні речовини або альгінати, спосіб одержання дозованої лікарської форми (варіанти) та спосіб лікування розладів, пов'язаних з диспепсією
PT96944726T PT813424E (pt) 1996-01-08 1996-12-20 Formas de dosagem farmaceutica oral que contem um inibidor da bomba de protoes e um agente antacido ou alginato
PCT/SE1996/001737 WO1997025066A1 (en) 1996-01-08 1996-12-20 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
DE69624907T DE69624907T3 (de) 1996-01-08 1996-12-20 Orale, pharmazeutische darreichungsformen, die einen protonenpumpeninhibitor und ein antacidum oder alginat enthalten
EE9700192A EE04002B1 (et) 1996-01-08 1996-12-20 Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja antatsiidainet või alginaati
TR97/00916T TR199700916T1 (xx) 1996-01-08 1996-12-20 Oral ispen�iyari dozaj formlar�.
JP9525131A JPH11501950A (ja) 1996-01-08 1996-12-20 プロトンポンプ抑制剤および制酸剤またはアルギネートを含有する経口用医薬剤形
CN96193594A CN1080125C (zh) 1996-01-08 1996-12-20 含有质子泵抑制剂和抗酸剂或藻酸盐的口服药物剂型
KR1019970706236A KR100490075B1 (ko) 1996-01-08 1996-12-20 양성자펌프억제제및제산제또는알기네이트함유경구제약제형
CA002213996A CA2213996C (en) 1996-01-08 1996-12-20 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
NZ325977A NZ325977A (en) 1996-01-08 1996-12-20 Composition comprising an enteric coated proton pump inhibitor and an antacid agent or alginate
RU97116726/14A RU2179453C2 (ru) 1996-01-08 1996-12-20 Пероральные фармацевтические лекарственные формы, включающие ингибитор протонного насоса и антацидное вещество или альгинат
DK96944726T DK0813424T4 (da) 1996-01-08 1996-12-20 Orale farmaceutiske doseringsformer omfattende en protonpumpeinhibitor og et syreneutraliserende middel eller alginat
AU13241/97A AU712669B2 (en) 1996-01-08 1996-12-20 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
BRPI9607350-0A BR9607350B1 (pt) 1996-01-08 1996-12-20 forma de dosagem em tablete unitário múltiplo.
US08/750,934 US6183776B1 (en) 1996-01-08 1996-12-20 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
PL96322175A PL187075B1 (pl) 1996-01-08 1996-12-20 Farmaceutyczna postać dawkowana, sposób wytwarzania doustnej farmaceutycznej postaci dawkowanej i zastosowanie farmaceutycznej postaci dawkowanej
MX9706785A MX9706785A (es) 1996-01-08 1996-12-20 Formas de dosificacion farmaceutica oral que comprenden un inhibidor de la bomba de protones y un agente antiacido o alginato.
HU9904024A HU229153B1 (en) 1996-01-08 1996-12-20 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
ES96944726T ES2185817T5 (es) 1996-01-08 1996-12-20 Formas de dosificacion farmaceutica oral que comprenden un inhibidor de las bombas de protones y un agente antiacido o alginato.
SK1169-97A SK283695B6 (sk) 1996-01-08 1996-12-20 Viaczložková tabletová lieková forma, spôsob jej prípravy a jej použitie
IL12165196A IL121651A (en) 1996-01-08 1996-12-20 Multiple unit tableted dosage form comprising a proton pump inhibitor and antacid(s) or alginate(s)
EP96944726A EP0813424B2 (en) 1996-01-08 1996-12-20 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
AT96944726T ATE228009T1 (de) 1996-01-08 1996-12-20 Orale, pharmazeutische darreichungsformen, die einen protonenpumpeninhibitor und ein antacidum oder alginat enthalten
ARP960105899A AR005281A1 (es) 1996-01-08 1996-12-26 Composicion farceutica oral , procedimientos para su manufactura y uso de esa composicion farmaceutica para la preparacion de medicamentos. .
TW085116139A TW464514B (en) 1996-01-08 1996-12-27 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
ZA9610935A ZA9610935B (en) 1996-01-08 1996-12-30 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
MYPI97000065A MY116091A (en) 1996-01-08 1997-01-07 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
EG1897A EG23821A (en) 1996-01-08 1997-01-07 Oral pharmaceutical dosage forms comprising a protom pump inhibitor and an antacid agent or alginate
SA97170553A SA97170553B1 (ar) 1996-01-08 1997-01-15 اشكال معايرة جرعات صيدلانية تعطى بالفم تتضمن مثبط مضخة البروتون proton pump inhibitor وعامل مضاد للحموضة او الجينات alginate
IS4548A IS2716B (is) 1996-01-08 1997-08-20 Lyfjaform til inntöku sem samanstendur af prótónpumpuhemli og sýrubindandi lyfi eða algínati
NO19974071A NO326656B1 (no) 1996-01-08 1997-09-04 Orale, farmasoytiske doseringsformer innbefattende en protonpumpeinhibitor og et syrenoytraliserende middel eller alginat, fremgangsmate for fremstilling av slike doseringsformer og anvendelse derav.
HK98100847A HK1001763A1 (en) 1996-01-08 1998-02-05 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
HK98111792A HK1017992A1 (en) 1996-01-08 1998-11-06 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9600071A SE9600071D0 (sv) 1996-01-08 1996-01-08 New oral formulation of two active ingredients I

Publications (1)

Publication Number Publication Date
SE9600071D0 true SE9600071D0 (sv) 1996-01-08

Family

ID=20400969

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9600071A SE9600071D0 (sv) 1996-01-08 1996-01-08 New oral formulation of two active ingredients I

Country Status (35)

Country Link
US (1) US6183776B1 (sv)
EP (1) EP0813424B2 (sv)
JP (1) JPH11501950A (sv)
KR (1) KR100490075B1 (sv)
CN (1) CN1080125C (sv)
AR (1) AR005281A1 (sv)
AT (1) ATE228009T1 (sv)
AU (1) AU712669B2 (sv)
BR (1) BR9607350B1 (sv)
CA (1) CA2213996C (sv)
CZ (1) CZ293583B6 (sv)
DE (1) DE69624907T3 (sv)
DK (1) DK0813424T4 (sv)
EE (1) EE04002B1 (sv)
EG (1) EG23821A (sv)
ES (1) ES2185817T5 (sv)
HK (2) HK1001763A1 (sv)
HU (1) HU229153B1 (sv)
IL (1) IL121651A (sv)
IS (1) IS2716B (sv)
MX (1) MX9706785A (sv)
MY (1) MY116091A (sv)
NO (1) NO326656B1 (sv)
NZ (1) NZ325977A (sv)
PL (1) PL187075B1 (sv)
PT (1) PT813424E (sv)
RU (1) RU2179453C2 (sv)
SA (1) SA97170553B1 (sv)
SE (1) SE9600071D0 (sv)
SK (1) SK283695B6 (sv)
TR (1) TR199700916T1 (sv)
TW (1) TW464514B (sv)
UA (1) UA45392C2 (sv)
WO (1) WO1997025066A1 (sv)
ZA (1) ZA9610935B (sv)

Families Citing this family (124)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US20050054682A1 (en) * 1996-01-04 2005-03-10 Phillips Jeffrey O. Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
SE9600071D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
AU5446798A (en) * 1996-11-27 1998-06-22 Procter & Gamble Company, The Compositions and methods for the treatment of gastrointestinal disorders
MX9703918A (es) * 1997-05-28 1998-11-30 J Marshall M D Barry Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.
SE510650C2 (sv) 1997-05-30 1999-06-14 Astra Ab Ny förening
WO1999010000A1 (en) * 1997-08-25 1999-03-04 The Procter & Gamble Company Combined preparations for treating upper gastrointestinal tract distress
ATE303809T1 (de) * 1997-12-08 2005-09-15 Altana Pharma Ag Orale verabreichungsform enthaltend einen protonenpumpeninhbitor (z.b. pantoprazole)
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
SE9704870D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
FR2774906B1 (fr) * 1998-02-13 2000-05-12 Rhodia Chimie Sa Systeme d'encapsulation a coeur organique et a ecorce minerale a base d'hydroxycarbonate d'aluminium et son procede de preparation
DK2263660T3 (en) 1998-05-18 2018-01-02 Takeda Pharmaceuticals Co Orally disintegrating tablets.
UA69413C2 (uk) * 1998-05-22 2004-09-15 Брістол-Майерс Сквібб Компані Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції
US7122207B2 (en) 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition
CA2581111A1 (en) 1998-07-28 2000-02-10 Takeda Pharmaceutical Company Limited Rapidly disintegrable solid preparation
SE9803772D0 (sv) * 1998-11-05 1998-11-05 Astra Ab Pharmaceutical formulation
EP1244430A4 (en) * 1999-03-29 2004-01-14 Wyeth Corp COATING SYSTEM
JP2003504338A (ja) * 1999-07-12 2003-02-04 スミスクライン・ビーチャム・コーポレイション 胸やけの処置法
WO2001028559A1 (fr) 1999-10-20 2001-04-26 Eisai Co., Ltd. Procede de stabilisation de composes benzimidazoles
US20040191276A1 (en) * 1999-11-30 2004-09-30 Cutispharma, Inc. Compositions and kits for compounding pharmaceuticals
AU2001296908A1 (en) * 2000-09-29 2002-04-08 Geneva Pharmaceuticals, Inc. Proton pump inhibitor formulation
US20020192299A1 (en) * 2000-12-28 2002-12-19 Rajneesh Taneja Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
SE0101379D0 (sv) * 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
PL367686A1 (en) * 2001-07-16 2005-03-07 Astrazeneca Ab Pharmaceutical formulation comprising a proton pump inhibitor and antacids
AR036354A1 (es) * 2001-08-31 2004-09-01 Takeda Chemical Industries Ltd Preparacion solida
CN1592611A (zh) * 2001-09-28 2005-03-09 麦克内尔-Ppc股份有限公司 改良释放的剂型
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US7008777B2 (en) 2001-10-15 2006-03-07 Barry J. Marshall System for the detection of urease and method for using same
JP2005521662A (ja) * 2002-01-25 2005-07-21 サンタラス インコーポレイティッド プロトンポンプ阻害剤の経粘膜送達
KR100479637B1 (ko) * 2002-02-01 2005-03-31 한국화학연구원 란소프라졸을 함유하는 경구제제 및 그의 제조방법
CO5400144A1 (es) * 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
CN100553625C (zh) 2002-04-09 2009-10-28 弗拉梅技术公司 活性成分微囊的口服混悬液
US20030228363A1 (en) * 2002-06-07 2003-12-11 Patel Mahendra R. Stabilized pharmaceutical compositons containing benzimidazole compounds
US20040081700A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Dose titratable liquid dosage forms of acid labile drugs
US20040082618A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of acid labile drugs
US6663892B1 (en) * 2002-08-19 2003-12-16 L. Perrigo Company Multiple portion tablet
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US8697094B2 (en) * 2002-10-16 2014-04-15 Takeda Pharmaceutical Company Limited Stable solid preparations
SE0203065D0 (sv) * 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
US9107804B2 (en) * 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
US20070243251A1 (en) * 2002-12-20 2007-10-18 Rajneesh Taneja Dosage Forms Containing A PPI, NSAID, and Buffer
US20040121004A1 (en) * 2002-12-20 2004-06-24 Rajneesh Taneja Dosage forms containing a PPI, NSAID, and buffer
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US20040166162A1 (en) * 2003-01-24 2004-08-26 Robert Niecestro Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
US7258981B2 (en) * 2003-01-24 2007-08-21 Clontech Laboratories, Inc. Sensitive proteasome sensor constructs and methods for their design and use
JP2006518751A (ja) * 2003-02-20 2006-08-17 サンタラス インコーポレイティッド 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物
EP1759692A3 (en) * 2003-03-10 2007-09-12 Novartis AG Taste-masked solid veterinary compositions
WO2004082692A1 (ja) * 2003-03-18 2004-09-30 Kowa Co., Ltd. 制酸剤組成物
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20050031700A1 (en) * 2003-07-18 2005-02-10 Sanatarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
CA2531564C (en) * 2003-07-18 2016-01-19 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
WO2005011637A1 (ja) * 2003-08-04 2005-02-10 Eisai Co., Ltd. 用時分散型製剤
US7282050B2 (en) * 2003-10-31 2007-10-16 Medtronic, Inc. Ablation of exterior of stomach to treat obesity
US7252665B2 (en) * 2003-10-31 2007-08-07 Medtronic, Inc Ablation of stomach lining to reduce stomach acid secretion
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US7041124B2 (en) * 2003-12-23 2006-05-09 Kimberly-Clark Worldwide, Inc. System and method for providing therapy to a portion of a body
GB0403165D0 (en) * 2004-02-12 2004-03-17 Ct Novel uses for proton pump inhibitors
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2005123042A1 (en) * 2004-06-10 2005-12-29 Glatt Air Techniques, Inc. Controlled release pharmaceutical formulation
US20050281876A1 (en) 2004-06-18 2005-12-22 Shun-Por Li Solid dosage form for acid-labile active ingredient
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
GB2418854B (en) * 2004-08-31 2009-12-23 Euro Celtique Sa Multiparticulates
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
US20060105039A1 (en) * 2004-10-21 2006-05-18 Jin-Wang Lai Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US20060165797A1 (en) * 2005-01-12 2006-07-27 Pozen Inc. Dosage form for treating gastrointestinal disorders
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
SE530605C2 (sv) * 2005-09-29 2008-07-15 Barbara Nelson Läkemedel innehållande ett syrahämmande medel, avseende att användas för att motverka och bota luftvägssjukdomar
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
BRPI0620787A2 (pt) * 2005-12-28 2011-11-22 Takeda Pharmaceutical preparação sólida
CN101453993A (zh) * 2006-04-03 2009-06-10 伊萨·奥迪迪 含有机溶胶涂层的受控释放递送物件
WO2007122478A2 (en) * 2006-04-20 2007-11-01 Themis Laboratories Private Limited Multiple unit compositions
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
EP2026768B1 (en) * 2006-06-01 2018-02-28 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
AR056062A1 (es) 2006-06-05 2007-09-19 Bago Sa Labor Composicion farmaceutica antiacida en forma de polvo, preparacion farmaceutica que la comprende y proceso para su preparacion
CN101120930B (zh) * 2006-08-11 2010-09-29 石药集团中奇制药技术（石家庄）有限公司 一种奥美拉唑组合物及其制备方法
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
MX2009004475A (es) 2006-10-27 2009-08-12 Univ Missouri Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma.
US20080194307A1 (en) * 2007-02-13 2008-08-14 Jeff Sanger Sports-based game of chance
CN101259140B (zh) * 2007-03-08 2012-08-22 重庆北碚现代应用药物研究所 一种治疗胃炎、胃溃疡及十二指肠溃疡的复方药物及其制备方法
US9597293B2 (en) * 2007-05-07 2017-03-21 Evonik Röhm Gmbh Solid dosage forms comprising an enteric coating with accelerated drug release
EP2044929A1 (en) * 2007-10-04 2009-04-08 Laboratorios del Dr. Esteve S.A. Oral fast distintegrating tablets
ITFI20070253A1 (it) * 2007-11-09 2009-05-10 Valpharma Internat S P A Formulazioni farmaceutiche per la somministrazione di ipp.
US8247440B2 (en) 2008-02-20 2012-08-21 Curators Of The University Of Missouri Composition comprising omeprazole, lansoprazole and at least one buffering agent
EP2127643A1 (de) * 2008-05-30 2009-12-02 Bayer Schering Pharma Aktiengesellschaft Orale Pelletformulierungen mit zeitversetzter Wirkstofffreigabe
JP2012502015A (ja) 2008-09-09 2012-01-26 アストラゼネカ・アクチエボラーグ 必要がある患者に医薬組成物を送達するための方法
WO2010038241A2 (en) * 2008-09-30 2010-04-08 Panacea Biotec Limited Pharmaceutical compositions comprising of proton pump inhibitor, prokinetic agent and alginic acid
JP2012072061A (ja) * 2009-01-29 2012-04-12 Eisai R & D Management Co Ltd 新規組成物
EA201290026A1 (ru) 2009-06-25 2012-07-30 Астразенека Аб Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid)
WO2010151697A1 (en) * 2009-06-25 2010-12-29 Pozen Inc. Method for treating a patient in need of aspirin therapy
CN102958515A (zh) 2009-12-02 2013-03-06 阿普塔利斯制药有限公司 非索非那定微胶囊及含有非索非那定微胶囊的组合物
WO2011080500A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2519229A2 (en) 2009-12-29 2012-11-07 Novartis AG New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011085181A1 (en) * 2010-01-08 2011-07-14 Eurand, Inc. Taste masked topiramate composition and an orally disintegrating tablet comprising the same
WO2011131203A2 (en) 2010-04-23 2011-10-27 S-Biotek Holding Aps A solid pharmaceutical composition for neutralizing stomach acid
WO2013101897A2 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
US20140127296A1 (en) * 2012-11-05 2014-05-08 Kenneth John Tibbs Pharmaceutical preparation and method for treatment of diabetes
US20150238514A1 (en) * 2014-02-21 2015-08-27 William Armstrong Protective Supplement Configuration
EP3288556A4 (en) * 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
SG11201809555QA (en) * 2016-04-29 2018-11-29 Alan Thompson Veterinary composition
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
TR201723199A2 (tr) * 2017-12-30 2019-07-22 Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi Yeni farmasötik bileşimler.
KR102080023B1 (ko) 2018-01-29 2020-02-21 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물
KR102006777B1 (ko) * 2018-01-29 2019-10-08 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 약제학적 제제
CN112839635A (zh) * 2018-08-23 2021-05-25 株式会社钟根堂 包含埃索美拉唑及碳酸氢钠的具有优秀的释放特性的药剂学制剂
MX2022004464A (es) * 2019-10-17 2022-05-03 Hanmi Pharm Ind Co Ltd Composicion farmaceutica que comprende un inhibidor de la bomba de protones y un antiacido.
EP4070789A4 (en) * 2020-01-23 2024-01-24 Hanmi Pharm Ind Co Ltd PHARMACEUTICAL COMPOSITE FORMULATION WITH PROTON PUMP INHIBITOR AND ANTACID
BR112022014430A2 (pt) * 2020-01-23 2022-09-13 Hanmi Pharm Ind Co Ltd Formulação farmacêutica composta
KR102608889B1 (ko) * 2020-07-14 2023-12-04 한미약품 주식회사 프로톤 펌프 저해제 및 제산제를 포함하는 약제학적 복합제제 및 그의 제조방법
WO2022103233A1 (ko) * 2020-11-13 2022-05-19 (주)휴온스 라베프라졸 및 제산제를 포함하는 약제학적 복합제제 및 이의 제조방법
CN114569579B (zh) 2020-12-02 2023-10-31 丽珠医药集团股份有限公司 肠溶微丸、其制备方法和包含它的制剂
KR20230097346A (ko) * 2021-12-24 2023-07-03 한미약품 주식회사 프로톤 펌프 저해제 및 제산제를 포함하는 경구용 복합정제의 제조방법 및 이에 의해 제조된 경구용 복합정제
KR102553713B1 (ko) * 2022-11-18 2023-07-10 고덕상 미네랄 촉매제를 이용한 양식어류사료 제조방법

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5535031A (en) 1978-09-04 1980-03-11 Shin Etsu Chem Co Ltd Enteric coating composition
JPS5598120A (en) 1979-01-16 1980-07-25 Shin Etsu Chem Co Ltd Preparation of drug having enteric coating
FR2471186A1 (fr) 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
US4340582A (en) 1981-01-15 1982-07-20 Abbott Laboratories Erythromycin base tablets
US4377568A (en) 1981-08-12 1983-03-22 Merck Sharp & Dohme (I.A.) Corp. Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same
DK150008C (da) 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
JPS5973529A (ja) 1982-10-12 1984-04-25 Sankyo Co Ltd 被覆固形製剤の製造法
US4525339A (en) 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
US4518433A (en) 1982-11-08 1985-05-21 Fmc Corporation Enteric coating for pharmaceutical dosage forms
GB2132887A (en) 1982-11-15 1984-07-18 Procter & Gamble Enteric-coated anti-inflammatory compositions
US4556552A (en) 1983-09-19 1985-12-03 Colorcon, Inc. Enteric film-coating compositions
US4716041A (en) 1984-02-10 1987-12-29 A/S Alfred Benzon Diffusion coated multiple-units dosage form
US4568560A (en) 1984-03-16 1986-02-04 Warner-Lambert Company Encapsulated fragrances and flavors and process therefor
SE450087B (sv) 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
EP0250572A1 (en) 1986-01-03 1988-01-07 The University Of Melbourne Gastro-oesophageal reflux composition
US5112813A (en) 1986-03-07 1992-05-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Process for the preparation of a viscosity-stable antacid composition
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
DK179687D0 (da) 1987-04-08 1987-04-08 Farma Food As Praeparat
KR960011236B1 (ko) † 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형
EP0294933B1 (en) † 1987-05-08 1992-03-11 Smith Kline & French Laboratories Limited Pharmaceutical compositions
GB8809421D0 (en) * 1988-04-21 1988-05-25 Fordonal Sa Antacid compositions with prolonged gastric residence time
JPH0482832A (ja) 1988-09-20 1992-03-16 Glaxo Group Ltd 医薬組成物
SE8803822D0 (sv) * 1988-10-26 1988-10-26 Novel dosage form
US5026559A (en) † 1989-04-03 1991-06-25 Kinaform Technology, Inc. Sustained-release pharmaceutical preparation
DE4023028A1 (de) * 1990-07-20 1992-01-23 Hoechst Ag Ferroelektrische fluessigkristalline si-enthaltende copolymere, ein verfahren zu ihrer herstellung, mischungen dieser copolymere mit niedermolekularen fluessigkristallen und die verwendung in elektrooptischen bauteilen
US5244670A (en) * 1991-04-04 1993-09-14 The Procter & Gamble Company Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress
IT1251153B (it) 1991-08-06 1995-05-04 Vectorpharma Int Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica
JP3142919B2 (ja) 1991-11-06 2001-03-07 旭化成株式会社 セルロース誘導体ラテックス及びその製法
US5160742A (en) 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
US5229137A (en) † 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn
US5447918A (en) 1992-07-27 1995-09-05 Mccullough; Ricky W. Gastrointestinal anti-irritant composition comprising sucralfate and methods of use
ATE217188T1 (de) 1992-08-05 2002-05-15 Faulding F H & Co Ltd Granulierte pharmazeutische zusammensetzung
US5330759A (en) 1992-08-26 1994-07-19 Sterling Winthrop Inc. Enteric coated soft capsules and method of preparation thereof
CA2110313C (en) † 1992-12-01 2004-10-26 Edward John Roche Pharmaceutical compositions containing a guanidinothiazole compound and antacids
WO1995001780A1 (en) † 1993-07-06 1995-01-19 Merck & Co., Inc. H2 antagonist-alginate combinations
WO1995001795A1 (en) 1993-07-06 1995-01-19 Merck & Co., Inc. H2 antagonist-alginate-antacid combinations
AU7833194A (en) 1993-09-20 1995-04-10 Procter & Gamble Company, The Use of triclosan phosphates for the treatment of gastrointestinal disorders due to heliobacter infection
JP3017906B2 (ja) 1993-10-08 2000-03-13 信越化学工業株式会社 腸溶性コーティング剤分散液
PT723777E (pt) † 1993-10-12 2002-11-29 Mitsubishi Pharma Corp Comprimido contendo granulos entericos
GB2285989A (en) 1994-01-28 1995-08-02 Merck Frosst Canada Inc Aqueous formulations for enteric coatings
AUPM596894A0 (en) 1994-05-30 1994-06-23 Hybrid Scientific Pty Ltd Composition for treating gastrointestinal disorders - a combination of bismuth salts plus lactobacillus or bifidobacteria species bacteria for treating gastrointestinal disorders
SE9402431D0 (sv) 1994-07-08 1994-07-08 Astra Ab New tablet formulation
PL180395B1 (pl) 1994-07-08 2001-01-31 Astra Ab Doustna farmaceutyczna tabletkowana postac dawkowania oraz sposób wytwarzania doustnej farmaceutycznej tabletkowanej postaci dawkowania PL PL PL PL PL PL PL PL PL PL
AUPM695294A0 (en) 1994-07-20 1994-08-11 Borody, Thomas Julius Improved combination therapy dose unit
WO1996029055A1 (en) 1995-03-17 1996-09-26 The Boots Company Plc Pectin liquid pharmaceutical compositions
US5824339A (en) † 1995-09-08 1998-10-20 Takeda Chemical Industries, Ltd Effervescent composition and its production
SE9600071D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
AU5446798A (en) 1996-11-27 1998-06-22 Procter & Gamble Company, The Compositions and methods for the treatment of gastrointestinal disorders

Also Published As

Publication number Publication date
WO1997025066A1 (en) 1997-07-17
CN1080125C (zh) 2002-03-06
PT813424E (pt) 2003-03-31
EP0813424A1 (en) 1997-12-29
CN1183047A (zh) 1998-05-27
AU1324197A (en) 1997-08-01
SA97170553B1 (ar) 2006-06-04
HK1001763A1 (en) 1998-07-10
CZ274797A3 (cs) 1998-03-18
EP0813424B1 (en) 2002-11-20
DK0813424T3 (da) 2003-03-10
TR199700916T1 (xx) 1997-12-21
AU712669B2 (en) 1999-11-11
KR100490075B1 (ko) 2005-09-08
NO326656B1 (no) 2009-01-26
IS2716B (is) 2011-02-15
HUP9904024A2 (hu) 2000-05-28
HUP9904024A3 (en) 2002-03-28
NO974071L (no) 1997-10-17
IL121651A0 (en) 1998-02-08
RU2179453C2 (ru) 2002-02-20
ES2185817T3 (es) 2003-05-01
DE69624907T3 (de) 2010-01-14
IS4548A (is) 1997-08-20
MX9706785A (es) 1997-11-29
BR9607350A (pt) 1997-12-30
NZ325977A (en) 1999-02-25
TW464514B (en) 2001-11-21
HK1017992A1 (en) 1999-12-10
EG23821A (en) 2007-09-19
AR005281A1 (es) 1999-04-28
EE9700192A (et) 1998-02-16
DE69624907D1 (de) 2003-01-02
ATE228009T1 (de) 2002-12-15
JPH11501950A (ja) 1999-02-16
ZA9610935B (en) 1997-07-08
EE04002B1 (et) 2003-04-15
NO974071D0 (no) 1997-09-04
KR19980702829A (ko) 1998-08-05
SK116997A3 (en) 1998-05-06
EP0813424B2 (en) 2009-08-05
US6183776B1 (en) 2001-02-06
SK283695B6 (sk) 2003-12-02
PL187075B1 (pl) 2004-05-31
MY116091A (en) 2003-11-28
PL322175A1 (en) 1998-01-19
DE69624907T2 (de) 2003-08-21
HU229153B1 (en) 2013-09-30
CA2213996C (en) 2006-08-29
ES2185817T5 (es) 2009-11-24
CA2213996A1 (en) 1997-07-17
BR9607350B1 (pt) 2010-08-10
UA45392C2 (uk) 2002-04-15
IL121651A (en) 2003-05-29
CZ293583B6 (cs) 2004-06-16
DK0813424T4 (da) 2009-11-09

Similar Documents

Publication Publication Date Title
SE9600071D0 (sv) New oral formulation of two active ingredients I
SE9600072D0 (sv) New oral formulation of two active ingredients II
SE9500422D0 (sv) New oral pharmaceutical dosage forms
MY119212A (en) Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid
CA2214027A1 (en) Multiple unit effervescent dosage forms comprising proton pump inhibitor
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
DE69636104D1 (de) Orale pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreigabe von Protonenpumpen-Hemmern
IS4329A (is) Fjöleiningaskammtar í töfluformi sem innihalda prótónupumpublokkara
HK1060045A1 (en) Formulations comprising ibuprofen and diphenhydramine and the use thereof for the treatment of sleepdisturbances
ATE232091T1 (de) Orale pharmazeutische zusammensetzungen mit verzögerter freisetzung von reversiblen protonpumpen-inhibitoren
CY1112510T1 (el) Φαρμακευτικο παρασκευασμα υπο τη μορφη παστας το οποιο περιεχει ενα ασταθες στα οξεα δραστικο συστατικο
ES2198195A1 (es) Forma de dosificacion farmaceutica oral comprimida, con recubrimiento enterico, que contiene un compuesto de bencimidazol labil en medio acido.
ATE251894T1 (de) Pharmazeutische zusammensetzungen zur oralen verabreichung
WO2002069968A8 (en) New use
RS49796B (sr) UPOTREBA SOLI 3α, 7α-DIHIDROKSI-12-KETO-5β-HOLANSKE KISELINE KAO AKTIVNE SUPSTANCE ZA IZRADU LEKOVA ZA LEČENJE DIJABETESA
RU2000117903A (ru) Способ лечения хронического гастрита и язвенной болезни двенадцатиперстной кишки
RU96102110A (ru) Способ профилактики и лечения изъязвлений роговицы
JO1881B1 (en) Formula II for multi unit disc calibration
SE9304065D0 (sv) New compound